Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 17, 2015

Primary Completion Date

July 6, 2015

Study Completion Date

July 13, 2015

Conditions
HIV
Interventions
DRUG

Bictegravir

75 mg tablet administered orally

Trial Locations (7)

1010

Auckland Clinical Studies Limited, Grafton

8011

Christchurch Clinical Studies Trust, Christchurch

32720

Avail Clinical Research, DeLand

32809

Orlando Clinical Research Center, Orlando

37920

New Orleans Center for Clinical Research, Knoxville

55114

Prism Clinical Research, Saint Paul

33014-3616

Clinical Pharmacology of Miami, Inc., Miami

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY